Allspring Global Investments Holdings LLC Has $99.56 Million Stock Position in Astera Labs, Inc. $ALAB

Allspring Global Investments Holdings LLC boosted its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 25.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 554,444 shares of the company’s stock after purchasing an additional 111,502 shares during the period. Allspring Global Investments Holdings LLC owned about 0.33% of Astera Labs worth $99,556,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in ALAB. Nordea Investment Management AB bought a new stake in shares of Astera Labs during the fourth quarter worth $2,028,000. Geneva Partners LLC bought a new position in Astera Labs in the 3rd quarter worth approximately $1,876,000. Numerai GP LLC lifted its holdings in Astera Labs by 153.1% during the 3rd quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock worth $2,587,000 after buying an additional 7,992 shares in the last quarter. Handelsbanken Fonder AB lifted its holdings in Astera Labs by 289.5% during the 3rd quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company’s stock worth $24,710,000 after buying an additional 93,800 shares in the last quarter. Finally, Corient Private Wealth LLC acquired a new position in shares of Astera Labs during the second quarter valued at $543,000. 60.47% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on ALAB shares. Weiss Ratings downgraded shares of Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday, February 23rd. Northland Securities lifted their price objective on Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 9th. Morgan Stanley reissued an “overweight” rating and issued a $210.00 target price on shares of Astera Labs in a research note on Wednesday, December 3rd. Barclays set a $165.00 target price on Astera Labs in a research report on Thursday, January 15th. Finally, Citigroup lowered their price target on Astera Labs from $275.00 to $250.00 and set a “buy” rating for the company in a research note on Wednesday, February 11th. Fifteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and an average price target of $202.22.

Astera Labs Price Performance

NASDAQ:ALAB opened at $109.60 on Wednesday. The business’s 50-day simple moving average is $135.19 and its 200-day simple moving average is $161.12. Astera Labs, Inc. has a fifty-two week low of $47.13 and a fifty-two week high of $262.90. The stock has a market capitalization of $18.77 billion, a PE ratio of 89.84, a price-to-earnings-growth ratio of 1.97 and a beta of 1.74.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.51 by $0.07. The business had revenue of $270.58 million during the quarter, compared to analysts’ expectations of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.Astera Labs’s revenue for the quarter was up 91.8% compared to the same quarter last year. During the same period in the prior year, the business earned $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, research analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Insider Activity at Astera Labs

In other news, Director Jack R. Lazar sold 7,500 shares of the business’s stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $119.80, for a total value of $898,500.00. Following the sale, the director owned 87,351 shares of the company’s stock, valued at $10,464,649.80. The trade was a 7.91% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, COO Sanjay Gajendra sold 94,971 shares of the stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the transaction, the chief operating officer owned 1,531,301 shares of the company’s stock, valued at $189,590,376.81. The trade was a 5.84% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 384,292 shares of company stock valued at $48,724,919 over the last ninety days. Company insiders own 12.50% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.